In an unprecedented move, the Food and Drug Administration (FDA) has greenlit Eroxon, an over-the-counter topical gel designed to treat erectile dysfunction (ED).
Eroxon, developed by British pharmaceutical company Futura Medical, is the first of its kind—no prescription necessary. This groundbreaking approval marks a significant stride in ED treatment, promising faster results, ease of use, and greater accessibility for those in need.
Apply this clear, odorless gel ten minutes before sexual activity and voila, you're good to go. Clinical trials have validated its effectiveness, with up to 65% of men achieving and maintaining an erection within a ten-minute window. So, men, prepare to bid farewell to the anxiety-ridden wait for oral ED meds to kick in—Eroxon is here to change the game.
The manufacturer, Futura Medical, has not yet announced a specific launch date. However, some analysts predict that Eroxon could be available in US stores in 2025.
The delay in the US launch is due to a number of factors, including the need to find a partner to distribute the product and the need to comply with FDA regulations.
Futura Medical is currently in talks with several potential partners, and they are confident that Eroxon will be available in the US in the near future.
In the meantime, Eroxon is available in other countries, including the UK, where it costs the equivalent of about $31 for a four-pack.
Do you dread those awkward doctor visits for your ED prescriptions? Does waiting an hour for Viagra to kick in feel like an eternity? Wish you could just pop over to the store for a quick fix?
Here comes Eroxon, the FDA-approved, over-the-counter remedy to your ED woes, promising not just accessibility but a quick turnaround time too.
When a pea-size amount of the medication is applied to the head of the penis, the gel evaporates and cools the skin before gradually becoming warm.
The fast-acting medication works in less than 10 minutes and "has a low incidence of side effects," which are limited to "local skin reactions." It contains ingredients such as ethanol (alcohol), glycerine (also known as glycerol) and carbomer (polymers).
Clinical trials have shown Eroxon's effectiveness with 60% to 65% of men achieving and maintaining an erection within ten minutes. Eroxon's magic? It stimulates nerve endings, releasing nitric oxide, which relaxes smooth muscles in the penis, increasing blood flow, and resulting in an erection.
It consists of ethanol, propylene glycol, glycerine (also known as glycerol), carbomer and potassium hydroxide. But he star of this show? Alprostadil, the active ingredient in Eroxon. It's a lab-made double of a hormone our bodies naturally produce, and it's got one job: widen those blood vessels and get the blood flow going.
Alprostadil is not new. A lot of porn stars use it, but hang on to your foreskins because you won't believe how they apply it: Injections and suppositories (and we don't mean up your bum. Keep reading).
You can have Alprostadil shot directly into your penis. Or, you can opt for a more...shall we say...unique approach, and use it as a suppository, nudging it right into the tip of the penis.
You read that right--placing it inside the tip of your penis. Yowza!
Now, this injectable wonder goes by a few monikers—Caverject, Edex, and Prostin VR. If suppositories are more your speed, you're looking for something called "MUSE"—a nifty acronym for Medicated Urethral System for Erection.
Alprostadil is strictly for men with erectile dysfunction. Play it fast and loose, and you could end up doing some lasting damage to your prized possession.
Wondering if it's worth the hype? Well, the injectable form has a pretty solid track record. It's helped more than 80% of men with erectile dysfunction to stand to attention, regardless of their age or the cause of their ED.
The suppository, though? It's a bit more hit or miss. It only gives the green light to an erection in about 30%-40% of men with ED.
But Alprostadil in Eroxon? That's a penis of a different color. It has one up on the other ED treatments because it's a no-fuss, no muss solution. No jabs, no gadgets, just a simple gel you rub on the main event. Discreet? Check. Convenient? Double-check.
Plus, it's a skin-deep solution, which means side effects are generally low key compared to other treatments.
So how does it do its magic? It's simple. Eroxon makes the smooth muscle tissue in the penis kick back and relax, allowing blood to flood into the erectile tissue and voila, an erection. The medication seeps through the skin, sinking into the tissue below, where it gets the blood vessels to expand, and the blood starts flowing.
Now, let's talk results. The most recent trial, starring 96 men, showed that over 60% of the Eroxon users had a "clinically meaningful improvement" in their ED situation, according to Futura Medical. That's the UK-based company behind the magic gel.
They had a side-by-side group taking the prescription drug Cialis. Now, while this pill had a better hit rate at tackling ED, it was a bit of a slowpoke—taking 30 to 60 minutes to kick in.
Dr. Arthur Burnett, a urology professor, the director of the Basic Science Laboratory in Neuro-Urology at Johns Hopkins University, and the lead investigator of Eroxon's clinical trial, talked to The Washington Post. "This is a different route for treatment that we believe is effective. It's a fascinating new therapy, and I think it's expanding our treatment options."
But not everyone's sold on the Eroxon express.
Dr. Stanton Honig, a urology professor and the head honcho of sexual and reproductive health at Yale School of Medicine, also chatted with The Washington Post. He's got his scientist hat on and is asking: 'Where's the statistical evidence that this stuff is better than a placebo?' He's yet to find a published paper that answers his question.
This recent study didn't put Eroxon head-to-head with an inactive placebo. However, past studies have used Eroxon as the placebo, comparing it to other ED drugs on the market.
Like all treatments, Eroxon isn't without its side effects. The common ones include mild redness, itching, and a burning sensation. But don't let that scare you away. These are generally well-tolerated and Eroxon has earned its seal of approval in the medical community.
However, not everyone can join the Eroxon party. If you're on other ED medications, like Viagra or Cialis, or have certain medical conditions such as heart disease or high blood pressure, it's best to give this one a miss.
And if you're worried about affordability, it's got you covered too. Priced at approximately $31 for a 4-pack, it's not covered by insurance but is definitely easier on the pocket than many alternatives.
Eroxon has been making waves across the pond. Already available over-the-counter in the United Kingdom and European Union, it boasts of a fast-acting mechanism that makes it a popular choice.
Futura Medical, the British pharmaceutical company producing Eroxon, claims the gel helps men get an erection within ten minutes — significantly faster than oral options like Viagra, which can take around 30 to 60 minutes to kick in.
Eroxon was classified as a "de novo" medical device by the FDA. This is a BIG deal. It means that Eroxon is the first topical gel that is approved for the over-the-counter treatment of erectile dysfunction (ED) in the United States.
Whoa, wait a minute. Eroxon is a gel, not a device, so why is the FDA calling it a medical device?
the FDA classifies medical products based on their intended use, not their physical form. In the case of Eroxon, the intended use is to treat ED, which is a medical condition. Therefore, the FDA classified Eroxon as a medical device.
The FDA's classification of Eroxon as a medical device is important because it means that the product is subject to the same regulations as other medical devices. This ensures that Eroxon is safe and effective for its intended use.
The FDA's de novo classification pathway is used for devices that are new to the market and do not have a predicate device. In the case of Eroxon, there was no other topical gel that was approved for the over-the-counter treatment of ED, so the FDA had to start from scratch when it came to classifying the device.
The FDA considered the risk of Eroxon and the level of controls that are needed to ensure its safety and effectiveness. They determined that Eroxon is a low-risk device, and they classified it as a class II device. This means that Eroxon is subject to general and special controls, which are designed to ensure that the device is safe and effective.
The FDA's decision to classify Eroxon as a de novo medical device is a significant milestone in the development of new treatments for ED. It is the first time that a topical gel has been approved for the over-the-counter treatment of ED, and it provides men with a new, convenient, and easy-to-use option for treating ED.
The U.S. market for over-the-counter ED treatments is ripe for disruption. While pharmaceutical giant Sanofi has been making strides to transition its tadalafil product from prescription-only to OTC in the U.S., it encountered a pause from the FDA in 2022. Meanwhile, Eroxon's entry signals a revolution in making ED treatments more accessible to the American populace.
The crux of Eroxon's appeal is its fast mode of action. Just apply the gel and within ten minutes, you're ready to go. Compared to the waiting time of 30 to 60 minutes for oral medications such as Viagra and Cialis, Eroxon is clearly a winner in the speed department.
While Eroxon expands the options for men with ED, it's still not a cure. But it's a significant leap in making treatment accessible and hassle-free. It's a new day for men battling ED, with Eroxon leading the charge in the over-the-counter revolution. The future of ED treatment looks promising and Eroxon, with its fast-acting, accessible solution, is a testament to that.
Cue the mixed reactions: Eroxon, the new over-the-counter gel for erectile dysfunction, has the internet's fingers typing a mile a minute. Some hail it as the messiah of men's health, while others side-eye it with skepticism.
Those flashing the thumbs-up at Eroxon, are all about the convenience. "No more awkward doc visits," they say. It's over-the-counter, folks. That means grab and go, no prescriptions, no pharmacy line juggling.
Plus, it's a gel—slap it on and get down to business. It's easier than making toast. And side effects? Nothing like the wooziness or nausea that some guys get from those pesky ED pills.
But not everyone's hopping on the Eroxon train. A few furrowed brows are questioning its safety. "It's too new," they argue, "where's the long-term data?" Concerns about this novel product hover like a dark cloud, leaving a question mark on the horizon of Eroxon's smooth-sailing future.
Here are a few sample quotes we found interesting:
Now, let's talk results. The most recent trial, starring 96 men, showed that over 60% of the Eroxon users had a "clinically meaningful improvement" in their ED situation, according to Futura Medical. That's the UK-based company behind the magic gel.
They had a side-by-side group taking the prescription drug Cialis. Now, while this pill had a better hit rate at tackling ED, it was a bit of a slowpoke—taking 30 to 60 minutes to kick in.
Dr. Arthur Burnett, a urology professor, the director of the Basic Science Laboratory in Neuro-Urology at Johns Hopkins University, and the lead investigator of Eroxon's clinical trial, talked to The Washington Post. "This is a different route for treatment that we believe is effective. It's a fascinating new therapy, and I think it's expanding our treatment options."
But not everyone's sold on the Eroxon express.
Dr. Stanton Honig, a urology professor and the head honcho of sexual and reproductive health at Yale School of Medicine, also chatted with The Washington Post. He's got his scientist hat on and is asking: 'Where's the statistical evidence that this stuff is better than a placebo?' He's yet to find a published paper that answers his question.
This recent study didn't put Eroxon head-to-head with an inactive placebo. However, past studies have used Eroxon as the placebo, comparing it to other ED drugs on the market.
Like all treatments, Eroxon isn't without its side effects. The common ones include mild redness, itching, and a burning sensation. But don't let that scare you away. These are generally well-tolerated and Eroxon has earned its seal of approval in the medical community.
However, not everyone can join the Eroxon party. If you're on other ED medications, like Viagra or Cialis, or have certain medical conditions such as heart disease or high blood pressure, it's best to give this one a miss.
And if you're worried about affordability, it's got you covered too. Priced at approximately $31 for a 4-pack, it's not covered by insurance but is definitely easier on the pocket than many alternatives.
Eroxon has been making waves across the pond. Already available over-the-counter in the United Kingdom and European Union, it boasts of a fast-acting mechanism that makes it a popular choice.
Futura Medical, the British pharmaceutical company producing Eroxon, claims the gel helps men get an erection within ten minutes — significantly faster than oral options like Viagra, which can take around 30 to 60 minutes to kick in.
Eroxon was classified as a "de novo" medical device by the FDA. This is a BIG deal. It means that Eroxon is the first topical gel that is approved for the over-the-counter treatment of erectile dysfunction (ED) in the United States.
Whoa, wait a minute. Eroxon is a gel, not a device, so why is the FDA calling it a medical device?
the FDA classifies medical products based on their intended use, not their physical form. In the case of Eroxon, the intended use is to treat ED, which is a medical condition. Therefore, the FDA classified Eroxon as a medical device.
The FDA's classification of Eroxon as a medical device is important because it means that the product is subject to the same regulations as other medical devices. This ensures that Eroxon is safe and effective for its intended use.
The FDA's de novo classification pathway is used for devices that are new to the market and do not have a predicate device. In the case of Eroxon, there was no other topical gel that was approved for the over-the-counter treatment of ED, so the FDA had to start from scratch when it came to classifying the device.
The FDA considered the risk of Eroxon and the level of controls that are needed to ensure its safety and effectiveness. They determined that Eroxon is a low-risk device, and they classified it as a class II device. This means that Eroxon is subject to general and special controls, which are designed to ensure that the device is safe and effective.
The FDA's decision to classify Eroxon as a de novo medical device is a significant milestone in the development of new treatments for ED. It is the first time that a topical gel has been approved for the over-the-counter treatment of ED, and it provides men with a new, convenient, and easy-to-use option for treating ED.
The U.S. market for over-the-counter ED treatments is ripe for disruption. While pharmaceutical giant Sanofi has been making strides to transition its tadalafil product from prescription-only to OTC in the U.S., it encountered a pause from the FDA in 2022. Meanwhile, Eroxon's entry signals a revolution in making ED treatments more accessible to the American populace.
The crux of Eroxon's appeal is its fast mode of action. Just apply the gel and within ten minutes, you're ready to go. Compared to the waiting time of 30 to 60 minutes for oral medications such as Viagra and Cialis, Eroxon is clearly a winner in the speed department.
While Eroxon expands the options for men with ED, it's still not a cure. But it's a significant leap in making treatment accessible and hassle-free. It's a new day for men battling ED, with Eroxon leading the charge in the over-the-counter revolution. The future of ED treatment looks promising and Eroxon, with its fast-acting, accessible solution, is a testament to that.
Cue the mixed reactions: Eroxon, the new over-the-counter gel for erectile dysfunction, has the internet's fingers typing a mile a minute. Some hail it as the messiah of men's health, while others side-eye it with skepticism.
Those flashing the thumbs-up at Eroxon, are all about the convenience. "No more awkward doc visits," they say. It's over-the-counter, folks. That means grab and go, no prescriptions, no pharmacy line juggling.
Plus, it's a gel—slap it on and get down to business. It's easier than making toast. And side effects? Nothing like the wooziness or nausea that some guys get from those pesky ED pills.
But not everyone's hopping on the Eroxon train. A few furrowed brows are questioning its safety. "It's too new," they argue, "where's the long-term data?" Concerns about this novel product hover like a dark cloud, leaving a question mark on the horizon of Eroxon's smooth-sailing future.
Here are a few sample quotes we found interesting:
The crux of Eroxon's appeal is its fast mode of action. Just apply the gel and within ten minutes, you're ready to go. Compared to the waiting time of 30 to 60 minutes for oral medications such as Viagra and Cialis, Eroxon is clearly a winner in the speed department.
While Eroxon expands the options for men with ED, it's still not a cure. But it's a significant leap in making treatment accessible and hassle-free. It's a new day for men battling ED, with Eroxon leading the charge in the over-the-counter revolution. The future of ED treatment looks promising and Eroxon, with its fast-acting, accessible solution, is a testament to that.
Cue the mixed reactions: Eroxon, the new over-the-counter gel for erectile dysfunction, has the internet's fingers typing a mile a minute. Some hail it as the messiah of men's health, while others side-eye it with skepticism.
Those flashing the thumbs-up at Eroxon, are all about the convenience. "No more awkward doc visits," they say. It's over-the-counter, folks. That means grab and go, no prescriptions, no pharmacy line juggling.
Plus, it's a gel—slap it on and get down to business. It's easier than making toast. And side effects? Nothing like the wooziness or nausea that some guys get from those pesky ED pills.
But not everyone's hopping on the Eroxon train. A few furrowed brows are questioning its safety. "It's too new," they argue, "where's the long-term data?" Concerns about this novel product hover like a dark cloud, leaving a question mark on the horizon of Eroxon's smooth-sailing future.
Here are a few sample quotes we found interesting: